Response of Multiple Recurrent TaT1 Bladder Cancer to Intravesical Apaziquone (EO9): Comparative Analysis of Tumor Recurrence Rates-Reference-Cited by-同舟云学术

Response of Multiple Recurrent TaT1 Bladder Cancer to Intravesical Apaziquone (EO9): Comparative Analysis of Tumor Recurrence Rates

Published:2009-05 Issue:5 Volume:73 Page:1083-1086
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Jain Arun,Phillips Roger M.,Scally Andrew J.,Lenaz Gino,Beer Mario,Puri Rajiv

Publisher

Elsevier BV

Subject

Urology

Reference13 articles.

1. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase;Workman;Oncol Res,1994

2. EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models;Hendriks;Eur J Cancer,1993

3. EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group;Dirix;Eur J Cancer,1996

4. A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG);Pavlidis;Ann Oncol,1996

5. Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours;Phillips;Br J Cancer,1998

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trials;Cancer;2022-10-19

2. Iron(II)‐catalyzed Oxidative Coupling of Vicinal Diols and 2‐Amino‐1,4‐naphthoquinone for the Synthesis of Pyrrolonaphthoquinones and Furanonaphthoquinones;Asian Journal of Organic Chemistry;2021-11-07

3. Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage;Current Urology Reports;2019-11-28

4. Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer;Cancer Chemotherapy and Pharmacology;2019-03-13

5. Total synthesis of natural productsviairidium catalysis;Organic Chemistry Frontiers;2018